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 ABSTRACT 
 Major mastitis pathogens such as Staphylococcus 
aureus, Streptococcus agalactiae, Streptococcus uberis, 
Streptococcus dysgalactiae, and the coliforms are usu-
ally considered more virulent and damaging to the 
udder than minor mastitis pathogens such as Coryne-
bacterium bovis and coagulase-negative staphylococci 
(CNS). The current literature contains several studies 
detailing analyses with conflicting results as to whether 
intramammary infection (IMI) with the minor patho-
gens decreases, increases, or has no effect on the risk 
of a quarter acquiring a new intramammary infection 
(NIMI) with a major pathogen. To investigate the avail-
able scientific evidence regarding the effect of IMI with 
minor pathogens on the acquisition of NIMI with ma-
jor pathogens, a systematic review and meta-analysis 
were conducted. The total extant English- and French-
language literature in electronic databases was searched 
and all publications cited by relevant papers were in-
vestigated. Results from 68 studies were extracted from 
38 relevant papers. Random-effects models were used 
to investigate the effects of CNS and C. bovis on ac-
quisition of new IMI with any of the major pathogens, 
as well as individually for the minor pathogens and 
Staph. aureus. Significant heterogeneity among studies 
exists, some of which could be accounted for by using 
meta-regression. Overall, observational studies showed 
no effect, whereas challenge studies showed strong and 
significant protective effects, specifically when major 
pathogens were introduced into the mammary gland 
via methods bypassing the teat end. Underlying risk 
can account for several unmeasured factors, and stud-
ies with higher underlying risk found more protective 
effects of minor pathogens. Larger doses of challenge 
organisms reduced the protective effect of minor patho-
gens, and studies with more stringent diagnostic crite-
ria for pathogen IMI identified less protection. Smaller 
studies (those utilizing fewer than 40 cows) also showed 
a greater protective effect than larger studies. 
 Key words:   major pathogen ,  minor pathogen ,  protec-
tive effect ,  meta-analysis 
 INTRODUCTION 
 Major mastitis pathogens such as Staphylococcus 
aureus, Streptococcus agalactiae, Streptococcus uberis, 
Streptococcus dysgalactiae, and the coliforms are usu-
ally considered more virulent and damaging to the ud-
der than minor mastitis pathogens such as Corynebac-
terium bovis and CNS. Studies conducted over the past 
6 decades investigating the effects of minor pathogens 
on the risk of acquisition of major pathogen infections 
have yielded contradicting results (Green et al., 2002; 
Pyörälä and Taponen, 2009). Such studies vary widely 
in methodology. Experimental challenge studies involve 
inoculation of quarters with both minor and major 
pathogens or utilize natural infections with minor 
pathogens and experimentally induced infections with 
major pathogens. Infections have been introduced by 
intracisternal infusion, inoculation into the teat canal, 
or teat end exposure. Observational studies also exist 
that examine the interaction between natural infections 
with these 2 groups of pathogens in field settings. 
 Extreme heterogeneity exists among studies account-
ing for these interactions, and certain shortcomings 
of publications on this topic are recognized. Although 
a large number of mastitis pathogens exist in nature, 
only a few strains of pathogens are typically tested 
in laboratory settings. In addition, one of the roles of 
minor pathogens may be to prevent entry of major 
pathogens into the mammary gland, a situation that is 
certainly overcome by direct infusion of pathogens into 
the teat canal or cistern. Definition of an IMI provides 
some difficulty, as even mastitis experts are often in 
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disagreement over how infection is defined (Andersen 
et al., 2010). Numerous issues may affect the interac-
tions of minor and major pathogens within a quarter, 
cow, or herd. Differences such as anatomical features, 
immunological characteristics, previous infections, and 
other alterations in environment may play a role in 
susceptibility. Cow-level factors such as breed, season of 
calving, age, and stage of lactation may have an effect, 
and herd-level factors such as overall pathogen profile 
undoubtedly play a role, especially when random al-
location of pathogens is not used. Studies that fail to 
account for these factors leave themselves open to a 
great number of confounding issues.
Narrative reviews bring together the diversity in 
results found in the literature (Pyörälä and Taponen, 
2009; Pyörälä et al., 2011), and several papers have 
reviewed the effects of minor pathogen infections on ac-
quisition of a major-pathogen new IMI (NIMI), either 
as a section of an all-encompassing literature review or 
in the introduction or discussion of a primary research 
article investigating such interactions. These reviews 
are helpful in summarizing some of what has been 
shown to date, but none exist that utilize a systematic 
or statistical methodology in the processes of identifica-
tion of relevant studies, assessment of methodology and 
outcomes, and synthesis of the information covered. 
Many of the narrative reviews in the primary research 
literature focus on results similar to those obtained in 
the trial being described to support such results as hav-
ing been previously identified. With such diversity in 
findings, however, support is almost always possible to 
some degree, even when the authors are citing trials 
conducted 50 yr previous and involving only a handful 
of subjects. A systematic review, on the other hand, uses 
a transparent method to identify relevant literature, 
extract the required information, and summarize and 
synthesize the results of the included studies (Sargeant 
et al., 2006). Qualitative methods can be used to inves-
tigate the differences or similarities between studies, 
while quantitative methods seek to combine study re-
sults or investigate factors contributing to heterogene-
ity among studies. Because of the diverse publications 
and previous research concerning the effect of minor 
pathogens in bovine mastitis, a systematic review and 
meta-analysis was selected to shed further light on the 
information available on this topic. The objective of 
this paper was specifically to investigate the effect of 
minor pathogen IMI on the acquisition of a new major 
pathogen IMI in the bovine udder. Because substantial 
heterogeneity among studies was expected, the specific 
aim was to quantify and describe the sources of hetero-
geneity, rather than provide an overall estimate of the 
effect of minor pathogen IMI on major pathogen NIMI.
MATERIALS AND METHODS
Literature Search
An online literature search was conducted, consulting 
PubMed, CAB Abstracts, Agricola, and Google Schol-
ar. To identify papers referring to minor pathogens, 
key words such as minor, Corynebacter*, and coagulase-
negative staphylococc* were used. To include papers ref-
erencing major pathogens, the key words major, Staph* 
aureus, Staph*, Strep*, and coliform* were used. These 
were then combined (using AND statements) with the 
keywords mastitis, risk, and protect* to identify studies 
investigating these interactions. Studies in English or 
French were considered and were drawn from peer-re-
viewed journals, conference proceedings, book chapters, 
and theses. Upon initial reading of salient articles by 
the primary author, works cited in those articles that 
appeared to deal with the interactions between minor 
and major pathogens were also retrieved.
Additionally, 19 investigators listed as authors on 
papers addressing this topic were contacted to identify 
any unpublished or difficult-to-locate studies related to 
the question of interest. Only one additional narrative 
review was identified by this route. Only manuscripts 
relating to mastitis pathogens of the bovine were in-
cluded, and papers needed to deal specifically with IMI 
caused by minor pathogens (as opposed to teat apex 
colonization, for instance) and NIMI caused by major 
pathogens (as opposed to clinical mastitis without de-
lineation of pathogen type, and so on).
Data Extraction
Three structured data collection forms (based on 
Sargeant et al., 2006) were devised and used for extrac-
tion of information. One form addressed general infor-
mation given in the paper, the second included specific 
questions relating to the study type described, and the 
third form provided a structure for extraction of the 
outcomes and raw data given in the manuscripts. Two 
independent investigators read and extracted informa-
tion simultaneously. The data extraction forms were 
initially tested on 5 included papers, and changes for 
clarity were addressed. Any differences in data extrac-
tion were discussed by the investigators, and consen-
sus was reached after further referring to the paper 
in question. If a paper reported more than one set of 
observations for separate minor or major pathogens, 
each pairing of pathogens was reported separately. If 
a paper reported the effect of a minor pathogen on 
a combined group of major pathogens (e.g., CNS vs. 
Staph. aureus, Strep. uberis, and Strep. dysgalactiae), or 
when raw data were presented that allowed this group-
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ing to be performed, these data were also extracted 
independently. Although results from studies reporting 
by treatment groups (e.g., lactational therapy groups, 
postmilking teat disinfection trials) were recorded sepa-
rately when details were provided in the manuscript, 
these were often combined in the meta-analysis due to 
inadequate group sizes for comparison.
Descriptive, study design, and study quality informa-
tion extracted from each study are listed in Table 1. 
Challenge studies and observational studies also had 
individual information relevant to their study design 
extracted.
If presented in individual manuscripts, quarter-level 
data were used to construct 2 × 2 tables for use in 
the meta-analysis. These raw data were available for 
all but 2 papers detailing challenge experiments and 
all but 8 papers reporting observational findings. Four 
manuscripts presented odds ratios (OR), 1 unadjusted 
from a case-control analysis (Lam et al., 1997) and 3 
adjusted from multilevel models (Schukken et al., 1999; 
Green et al., 2002, 2005), and either standard errors 
(SE) or 95% confidence intervals, from which SE could 
be calculated. Three articles (Hogan et al., 1988; Wool-
ford et al., 2001; Zadoks et al., 2001a) reported rates of 
new infections, and 3 others reported differing measures 
such as median difference of infection at the herd level 
(Michel et al., 2011), clinical differences (Spencer et al., 
1968), and coefficients from Poisson models (Zadoks 
et al., 2001b). Data from these 6 papers could not be 
included in the meta-analysis, although, as selections 
for the systematic review, their reported outcomes are 
discussed later in this manuscript.
Several manuscripts presented results for multiple 
minor and major pathogens, so individual study values 
were constituted using the raw data or reported OR. 
Studies from observational papers representing several 
different data collections (e.g., on lactating cows vs. 
dry cows) were represented separately. Exceptions to 
this occurred when there appeared to be no substantial 
differences between the trials or when the researchers 
themselves combined data in the original publication. 
Many challenge studies reported differing pathogens 
and amounts of pathogens used in challenges; these 
data were extracted as separate studies when sufficient 
detail was reported.
Meta-Analyses
Several meta-analyses were carried out to investigate 
the effect of minor pathogen IMI on the acquisition of 
NIMI with major pathogens (Table 2):
?? Manuscripts differed in the individual pathogens 
investigated, so a general meta-analysis compar-
ing the effect of both minor pathogens (CNS and 
C. bovis) on acquisition of NIMI with any major 
pathogens (Staph. aureus, Strep. agalactiae, Strep. 
uberis, Strep. dysgalactiae, Escherichia coli, and 
other pathogens such as Klebsiella spp. or envi-
ronmental streptococci) was initially performed.
?? Studies were then grouped as observational or 
challenge studies and a meta-analysis within each 
group was performed.
?? Separate meta-analyses investigating the effects of 
CNS and C. bovis individually on all major patho-
gens were also performed.
?? The effects of each minor pathogen on acquisition 
of NIMI with Staph. aureus were also investigated 
in separate meta-analyses.
Because a high degree of heterogeneity was identi-
fied among studies, random-effects meta-analyses us-
ing the method described by DerSimonian and Laird 
(1986) were performed. Odds ratios were selected as 
the measure of association to incorporate the results 
of the 4 papers not containing raw data but reporting 
OR and SE or 95% CI. To calculate OR for those 2 × 2 
tables with cells containing the value zero, an empirical 
continuity correction was used, as this is expected to 
decrease the amount of bias in estimation of effect in 
the subsequent meta-analyses (Sweeting et al., 2004).
Meta-Regressions
Meta-analysis regressions, or meta-regressions, were 
used to investigate the reasons for heterogeneity among 
studies. These analyses use data summarized at the 
study level to fit regression models with the natural log 
of the OR (lnOR) as the outcome variable.
First, all predictors described in Table 1 were investi-
gated for their contribution to heterogeneity using uni-
variable meta-regressions. Next, predictors of interest, 
as well as those showing association (P ≤ 0.05 before 
Bonferroni correction) with the lnOR, were combined 
in multivariable meta-regressions when the number of 
studies available made this possible. Finally, separate 
meta-regressions were fit for data sets involving any 
minor pathogen and any major pathogen, observational 
studies only, challenge studies only, CNS and major 
pathogens, C. bovis and major pathogens, CNS and 
Staph. aureus, and C. bovis and Staph. aureus.
Often such a small number of studies was included, 
especially in the individual CNS and C. bovis effects 
on Staph. aureus meta-regressions, that multivariable 
meta-regressions were not possible. Factors were ini-
tially combined with the 3-level study design variable 
and assessed for further significance. Those that ap-
peared to provide much the same information as study 
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Table 1. Descriptive, study design, and study quality information extracted from each of 68 studies included in the meta-analysis investigating 
the effect of CNS and Corynebacterium bovis IMI on acquisition of new IMI with major pathogens1 
Variable
No. of  
studies Description
Unconditional2 With study design3
P-value
R2  
(%) P-value
R2  
(%)
Descriptive information4       
 Publication year (range) 68 Range: 1965–2012 0.001 21.6 Collinear5  
 Publication source 68 Peer-reviewed, proceedings, other 0.08 5.3   
 Country 68 North America, Europe, other 0.05 1.4 0.02 15.9
 Breed 68 Holstein, Jersey, other 0.02 6.1 <0.0001 43.5
 Season 68 Spring, winter, all, ND6 0.0001 28.6 Collinear  
 Underlying risk (odds of disease) 60 Range: 0.01–36.2 <0.001 69.3 Intervening7  
 Total farms 61 Range: 1–91 0.27 −1.58   
 Total cows 55 Range: 2–6,825 – represented as 
quadratic
0.008 15.8 0.29 44.7
 No. of cows +minor 17 Range: 2–18  NS9 —   
 No. of cows +major 23 Range: 2–220 NS —   
 No. of quarters +minor 64 Range: 2–13,504 0.40 −2.3   
 No. of quarters +major 68 Range: 1–346 0.42 −2.6   
       
Study design information4       
 Study design 68 Observational, challenge (challenge-
challenge10, natural-challenge11)
0.04 7.8   
 Minor pathogen 68 CNS, Corynebacterium bovis 0.09 −0.4 0.26 7.6
 Farm type 68 Commercial farm(s), research facility, 
both
0.004 20.0 Collinear  
 Parity 68 Heifers, multiparous cows, both, ND 0.99 −8.0   
 Stage of lactation 68 Dry period only, lactation only, both 0.01 13.3 Collinear  
 Sampling frequency 60 Samples/week (range: 0.06–7.5) <0.001 29.3 Collinear  
 Sampling method 68 Single, duplicate samples 0.62 −3.4   
 IMI definition, minor 68 Required duplicate, consecutive, or 
clinical mastitis for diagnosis: yes, no, 
ND
<0.0001 40.5 <0.0001 50.1
 IMI threshold, minor 68 Three categories (cfu/mL), ND 0.04 0.2 0.02 12.6
 IMI definition, major 68 Required duplicate, consecutive, or 
clinical mastitis for diagnosis: yes, no, 
ND
0.0001 27.1 <0.0001 48.9
 IMI threshold, major 68 Three categories (cfu/mL), ND 0.06 0.1 0.01 14.7
 Used dry cow therapy? 68 All, some, none, ND, NA12 0.004 22.6 Collinear  
 Dry cow therapy 68 Antibiotics, teat sealant, ND, NA 0.005 21.3 Collinear  
 Postmilking teat dip 68 All, some, none, ND 0.05 3.8 0.0006 26.9
       
Study quality4       
 Specific objective of study? 68 Yes, no 0.10 4.2   
 Justified sample size? 68 Yes, no 0.03 7.8 0.09 11.3
 Loss to follow-up reported? 68 Yes, partial, no 0.004 12.6 0.007 17.7
 Percentage lost to follow-up 10 Range: 0–21% NS —   
 Conclusions supported by results? 68 Yes, no 0.36 0.4   
 Effect measure 68 Unadjusted, adjusted for other 
predictors
0.66 −1.9   
 Statistical control for clustering 68 Yes, no 0.53 −1.1   
 Confounders controlled 68 Parity, stage of lactation, other, none 0.89 −5.9   
       
Challenge studies only13       
 Protocols adequately described? 37 Yes, no 0.002 29.2 0.001 29.3
 Experimental unit, minor 37 Some quarters, NA 0.89 −3.5   
 Experimental unit, major 37 All quarters, some quarters 0.92 −3.3   
 Challenge allocation, minor 37 Simple random, blocked random, 
systematic, ND, NA
0.07 24.8   
 Challenge allocation, major 37 Simple random, systematic, ND, NA 0.85 −9.3   
 Inclusion of previously infected 
  quarters
37 All negative, negative major, positive 
minor or major, not tested
0.002 41.5 Collinear  
 Challenge administration, minor 37 Intracisternal, cannulation into teat 
duct/cistern, dip, ND, NA
<0.0001 67.5 Collinear  
 Challenge administration, major 33 Intracisternal, cannulation into teat 
duct/cistern, dip, ND, NA
0.0001 61.4 0.0001 57.1
 Pathogen dose, minor 28 ≤50,000 cfu, >50,000 cfu, ND 0.0001 60.4 Collinear  
 Pathogen dose, major 37 ≤500 cfu, >500 cfu, ND 0.001 47.9 0.002 39.4
Continued
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design (collinear) or were expected to be caused by 
study design (intervening) were not included in further 
modeling (Table 1). Multivariable models were then 
built using a manual stepwise procedure in an attempt 
to account for the most between-study heterogeneity 
while maintaining statistical significance (P ≤ 0.05) in 
the predictors. Factors within the multivariable model 
were also assessed for collinearity to ensure they were 
not representing the same information. Adjusted-R2 
values were used to indicate the relative reduction 
Table 2. Estimated effects from separate meta-analyses of minor pathogen IMI on acquisition of new IMI with major pathogens1 
Analysis 
No. of  
studies
Odds  
ratio 95% CI P-value τ2
Any minor pathogen/any major pathogen 68 0.68 0.52, 0.88 0.003 0.65
 Observational studies 31 1.02 0.75, 1.39 0.89 0.46
 Challenge studies 37 0.36 0.23, 0.59 <0.001 1.22
  Challenge-challenge studies2 28 0.31 0.15, 0.66 0.002 3.11
  Natural-challenge studies3 9 0.38 0.22, 0.67 0.001 0.25
CNS/major pathogen 33 0.52 0.35, 0.77 0.001 0.65
Corynebacterium bovis/major pathogen 35 0.81 0.52, 1.17 0.26 0.80
CNS/Staphylococcus aureus 21 0.57 0.33, 0.99 0.05 0.98
C. bovis/Staph. aureus 16 0.57 0.34, 0.94 0.03 0.69
1τ2 = between-study variance or heterogeneity.
2Challenge studies where quarters were experimentally challenged with a minor pathogen and subsequently with a major pathogen.
3Challenge studies where quarters were naturally infected with a minor pathogen and challenged with a major pathogen.
Table 1 (Continued). Descriptive, study design, and study quality information extracted from each of 68 studies included in the meta-analysis 
investigating the effect of CNS and Corynebacterium bovis IMI on acquisition of new IMI with major pathogens1 
Variable
No. of  
studies Description
Unconditional2 With study design3
P-value
R2  
(%) P-value
R2  
(%)
 Minor diagnosis to major challenge 
  interval
33 Range: 2–303 d <0.001 60.7 <0.001 60.5
 Sufficient interval for diagnosis? 37 Yes, no, ND 0.84 −4.2   
       
Observational studies only14       
 Representative housing? 31 Yes, ND 0.04 13.9   
 Farm selection 31 Convenience, purposive, random, ND 0.40 5.4   
 Indicate farm reason to decline? 31 Indicated, not indicated, single farm 0.28 4.9   
 Inclusion/exclusion criteria 31 Described, not described 0.30 5.6   
1Both unconditional associations from univariable meta-regressions with major pathogen infection and the association observed after controlling 
for study design in multivariable meta-regressions are reported.
2Values provided for univariable meta-regression analyses with single predictor. Adjusted-R2 = value of heterogeneity between studies accounted 
for by this predictor [amount of variance (τ2) accounted for by the model].
3Values provided for multivariable meta-regression analyses with predictor and 3-level variable for study design (only variables with uncondi-
tional P-values ≤ 0.05 before Bonferroni correction were evaluated further). Adjusted-R2 = same as in footnote 2.
4Thirty-four predictors evaluated, so P-values of unconditional associations <0.0015 would be considered significant using Bonferroni method 
for multiple comparisons.
5Variable represented much the same information as study design (collinear).
6ND = not described.
7Variable causes the outcome but occurs between study design and the outcome (intervening).
8R2 values <0 may occur when the predictor explains less variation than would be expected by chance (Harbord and Higgins, 2008).
9Reported by too few studies to give sensible values in meta-regression.
10Challenge studies where quarters were experimentally challenged both with a minor pathogen and subsequently with a major pathogen.
11Challenge studies where quarters were naturally infected with a minor pathogen and challenged with a major pathogen.
12NA = not applicable.
13Sixteen predictors evaluated, so P-values of unconditional associations <0.003 would be considered significant using Bonferroni method for 
multiple comparisons.
14Four predictors evaluated, so P-values of unconditional associations <0.01 would be considered significant using Bonferroni method for mul-
tiple comparisons.
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in the between-study variance (Harbord and Higgins, 
2008). To avoid type I errors occurring due to inclusion 
of multiple predictors in the multivariable meta-analy-
ses, a random permutation test based on Monte Carlo 
simulation was used to provide a multiplicity adjust-
ment of the P-values (Harbord and Higgins, 2008). To 
Figure 1. Flowchart detailing inclusion, exclusion, and categorization of manuscripts and studies included in the systematic review. Reasons 
for inclusion or exclusion are provided at each step of the systematic review. NIMI = new IMI.
Journal of Dairy Science Vol. 95 No. 11, 2012
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provide sufficient precision, the command was set to 
20,000 permutations, and results were compared with 
those obtained in the multivariable models.
Publication Bias or Small-Study Effects
A funnel plot was generated to evaluate the presence 
of publication bias or small-study effects. This plot sets 
the OR against its SE, thereby displaying the differenc-
es among effects of smaller studies and those of larger 
studies (Harbord et al., 2009). Lack of symmetry in the 
plot indicates that bias may be present or that small 
studies with large standard errors may be influencing 
the estimate of the effect size. Egger’s test for asym-
metry was chosen from among the possible options and 
applied to evaluate the evidence for publication bias or 
small-study effects (Harbord et al., 2009). All analyses 
were conducted using Stata 12IC (StataCorp, College 
Station, TX).
RESULTS
Literature Search
The literature search identified 267 abstracts, which 
were further investigated for relevance to the topic. 
After removal of manuscripts that did not include in-
formation relating to infection with minor and major 
mastitis pathogens, did not specify bacteriological in-
teraction, reported effects of minor pathogens without 
any information regarding major pathogen IMI, or did 
not directly address the specific question under investi-
gation (Figure 1), 38 manuscripts containing the results 
of 69 studies met the selection criteria for inclusion in 
the meta-analysis (Appendix Table A1). Of these, 35 
were published in peer-reviewed journals, 2 came from 
conference proceedings, and 1 was a thesis.
Descriptive Information
The papers included represented a wide range of re-
search conducted over 6 decades in several countries. 
Descriptive information here is provided for all papers, 
and information related specifically to the studies in-
cluded in the meta-analysis is listed in Table 1. Papers 
often contained several trials or observations about 
different minor and major pathogens. Manuscripts re-
ported results of analyses involving what they termed 
CNS, coagulase-negative micrococci, or simply micro-
cocci. These have been combined here and are referred 
to as CNS. Twenty-nine papers contained studies ex-
amining minor pathogen effects on NIMI with Staph. 
aureus (12 with CNS only, 11 with C. bovis, and 6 with 
both), whereas 13 papers contained studies with Strep. 
agalactiae as the outcome (6 with CNS, 6 with C. bovis, 
and 1 with both). Fifteen papers presented results of 
major infections with coliform bacteria (5 with CNS, 6 
with C. bovis, 4 with both). Studies were conducted in 
the United Kingdom (n = 9), United States (n = 8), 
Sweden (n = 5), Canada (n = 5), France (n = 3), the 
Netherlands (n = 3), New Zealand (n = 2), Denmark 
(n = 1), Finland (n = 1), and Switzerland (n = 1). 
Holstein cattle were mainly used, followed by Jersey 
cattle and other dairy breeds (Swedish Red and White, 
Guernsey, Friesian, Meuse-Rhine-Yssel). The total 
number of cows was often small for challenge studies 
(median = 19, mean = 64.5), although one multi-year 
challenge trial included 600 cows (Nickerson and Bod-
die, 1994), and papers often detailed the results of 
several challenge studies conducted on subsets of cows. 
Observational studies were much larger in terms of to-
tal cows (median = 255, mean = 673.4). A variety of 
definitions for IMI was found among the papers, with 
diagnostic criteria from 20 to 350 cfu/mL, and some 
papers required that IMI be present in consecutive 
samples, duplicate samples, or in samples from cows 
diagnosed with clinical mastitis to be considered in-
fected. These were categorized into 4 variables, 2 each 
for minor and major pathogen definitions: a thresh-
old category (<100, 100–299, and ≥300 cfu/mL) and 
a diagnosis classification (whether or not IMI needed 
to be diagnosed in consecutive, duplicate, or clinical 
mastitis samples). A subjective assessment of whether 
the conclusions of the authors were supported by the 
results presented in the paper was made by the data 
extractors.
All but one manuscript describing challenge experi-
ments were included in the meta-analysis. Spencer et 
al. (1968) gave a general impression that no effect 
of minor pathogens was elicited, but did not report 
any data that were usable in further analyses. Of the 
remaining 16 papers reporting challenge experiments, 
37 studies were compiled. Of these, challenge studies 
were separated into categories: “challenge-challenge” 
studies, where quarters were challenged with a minor 
pathogen and then challenged with a major pathogen 
(n = 17); “natural-challenge” studies, where quarters 
were naturally infected with minor pathogens before 
being challenged with major pathogens (n = 9); and 
“both-challenge” studies, where some quarters were 
naturally infected with minor pathogens and some were 
challenged with the same minor pathogen (to increase 
numbers in the minor-pathogen IMI group), and then 
all were challenged with a major pathogen (n = 9) (Fig-
ure 1). Two studies included quarters challenged with 
a minor pathogen (CNS) and then observed for natural 
infection with a major pathogen (Pankey et al., 1985), 
but these were combined with the observational study 
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group, because challenge with a major pathogen was 
believed to be the basis for an experimental challenge 
study (Figure 1). Twenty-two of the challenge studies 
involved CNS as the minor pathogen, and 15 challenge 
studies investigated the effects of C. bovis.
Of the 21 papers detailing observational work, 5 
did not contain data that could be used in the meta-
analysis (Figure 1). Hogan et al. (1988) reported 
rates of infection with minor and major pathogens, 
but extracting raw data from the information given 
was not possible. Michel et al. (2011) included only 
median differences of minor and major pathogen 
infections between herds and estimated a protective 
effect based on herd profile. Woolford et al. (2001) 
summarized a higher incidence of Strep. uberis infec-
tion in quarters infected with C. bovis, but did not 
provide any information with which to extract any 
further data. Zadoks et al. (2001b) reported a higher 
incidence of Strep. uberis in quarters infected with 
other pathogens (including minor pathogens) and also 
reported parameters in Poisson models (Zadoks et al., 
2001a), but this information could not be transformed 
into a format useful for meta-analysis. The other 16 
manuscripts comprised 31 usable individual studies. 
Of these, 11 reported on the effects of CNS, and 20 
represented the effects of C. bovis IMI.
Figure 2. Forest plot displaying a random-effects meta-analysis of the effect of CNS and Corynebacterium bovis IMI on acquisition of 
new IMI with major pathogens for observational studies. Lengths of horizontal lines represent 95% CI for the effect, black dots represent the 
individual odds ratio (OR) estimates of the studies, and gray squares are proportional to the weight given to each study. The dashed line rep-
resents the overall effect of all the studies (OR = 1.02), whereas the solid line represents the value for no effect (OR = 1). The diamond at 
the bottom of the dashed line represents the 95% CI for the overall effect of the observational studies (0.75, 1.39). Minor pathogens: CNS and 
Corynebacterium bovis; major pathogens: sa = Staphylococcus aureus, su = Streptococcus uberis, sd = Streptococcus dysgalactiae, coli = coliforms, 
sag = Streptococcus agalactiae, oth = other streptococci, Pseudomonas spp., yeast. ES = estimate of effect = OR. Color version available in the 
online PDF.
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In total, 69 studies were extracted from the 38 manu-
scripts. One study failed to find any major pathogen 
NIMI and thus was not expected to contribute to the 
overall meta-analysis (Sweeting et al., 2004), so it was 
removed, leaving 68 usable studies (Figure 1).
Meta-Analyses
Because of the extreme heterogeneity among stud-
ies in these meta-analyses, the values obtained for the 
estimates of overall OR cannot be expected to accu-
rately represent the effect of minor pathogen IMI on 
the acquisition of NIMI with major pathogens. Overall 
measures of effect are reported, but readers are cau-
tioned that these overall measures may be of limited 
use due to the substantial differences among the studies 
included in these meta-analyses.
The estimated effects of minor pathogen IMI on ac-
quisition of a major pathogen NIMI are given in Table 
2 and are illustrated in forest plots in Figures 2, 3, and 
4 (separated by type of study). A significant protective 
effect was seen for the effects of all minor pathogens on 
acquisition of NIMI with all major pathogens. Because 
study design was expected to be a major contributor to 
the heterogeneity among studies, it was broken down 
into sub-groups and analyzed separately. A significant 
Figure 3. Forest plot displaying a random-effects meta-analysis of the effect of CNS and Corynebacterium bovis IMI on acquisition of new 
IMI with major pathogens for “challenge-challenge” studies. Lengths of horizontal lines represent 95% CI for the effect, black dots represent 
the individual odds ratio (OR) estimates of the studies, and gray squares are proportional to the weight given to each study. The dashed line 
represents the overall effect of all the challenge-challenge studies (OR = 0.31), whereas the solid line represents the value for no effect (OR = 
1). The diamond at the bottom of the dashed line represents the 95% CI for the overall effect of the challenge-challenge studies (0.14, 0.66). 
Minor pathogens: CNS and Corynebacterium bovis; major pathogens: sa = Staphylococcus aureus, su = Streptococcus uberis, sd = Streptococcus 
dysgalactiae, coli = coliforms, sag = Streptococcus agalactiae, oth = other streptococci, Pseudomonas spp., yeast. ES = estimate of effect = OR. 
Color version available in the online PDF.
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protective effect was present in challenge studies; no 
effect was seen among observational studies (Table 2). 
Considerable between-study heterogeneity (τ2) existed, 
most notably in the challenge-challenge studies (Table 
2, Figure 3).
A sensitivity analysis was conducted on the full data 
set by removing studies individually and assessing 
change in effect. No one study was influential enough 
to alter the OR estimate from the statistically signifi-
cant protective range (data not shown). Removal of all 
12 studies by the research group of Linde and cowork-
ers (Linde et al., 1975a,b, 1976, 1980; Linde, 1982), 
however, shifted the overall OR estimate to 0.84 (95% 
CI: 0.65, 1.10), a statistically nonsignificant effect (P 
= 0.20).
Meta-Regressions
A specific aim of this research was to describe and 
quantify the heterogeneity among studies that exists in 
the literature to identify areas of difference that might 
explain the divergent effects of minor pathogens re-
ported through the years. Univariable meta-regressions 
revealed that several predictors had significant influ-
ence on the OR estimates, even when a Bonferroni cor-
rection was applied (Table 1).
Minor Pathogens and Study Design. Little 
evidence was found of the presence of either CNS 
or C. bovis contributing to the heterogeneity in OR 
among studies in the data set including both minor 
pathogens (P = 0.09, adjusted R2 = −0.4%); therefore, 
this variable was not included in further multivariable 
meta-regressions. Overall, OR in challenge studies were 
significantly lower than those found in observational 
studies (P = 0.01). To further delineate the nature of 
this relationship, the categories of challenge studies were 
separated; this increased the R2 to 37.9%, and showed 
that the majority of the difference in effect came from 
the both-challenge studies, those where quarters were 
challenged with minor pathogens or could be naturally 
infected with minor pathogens before major pathogen 
challenge. Studies in the both-challenge category were 
significantly more likely to show a protective effect of 
minor pathogens (P < 0.001) compared with obser-
Figure 4. Forest plot displaying a random-effects meta-analysis of the effect of CNS and Corynebacterium bovis IMI on acquisition of new 
IMI with major pathogens for “natural-challenge” studies. Lengths of horizontal lines represent 95% CI for the effect, black dots represent the 
individual odds ratio (OR) estimates of the studies, and gray squares are proportional to the weight given to each study. The dashed line rep-
resents the overall effect of all the natural-challenge studies (OR = 0.38), whereas the solid line represents the value for no effect (OR = 1). 
The diamond at the bottom of the dashed line represents the 95% CI for the overall effect of the natural-challenge studies (0.22, 0.67). Minor 
pathogens: CNS and Corynebacterium bovis; major pathogens: sa = Staphylococcus aureus, su = Streptococcus uberis, coli = coliforms, sag = 
Streptococcus agalactiae. ES = estimate of effect = OR. Color version available in the online PDF.
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vational studies; compared with no effect (OR = 1), 
both-challenge studies were more likely to show sub-
stantial protection (OR = 0.06). Studies in the natural-
challenge category were also significantly more likely 
to show protection (P = 0.04, protection of OR = 0.33 
compared with no effect), whereas the OR of challenge-
challenge studies were not predicted to be significantly 
different from those generated by observational stud-
ies. Ten of the 11 studies in the both-challenge group 
were conducted by one research group (Linde and 
coworkers), however, and the overall methods of this 
research group were believed to account for the major-
ity of these differences. Because all of these studies had 
animals that were challenged with a minor pathogen, 
these 11 both-challenge studies were combined with the 
challenge-challenge group to form a 3-level categorical 
variable for study design (observational, challenge-chal-
lenge, and natural-challenge). As this set of variables 
was believed to confound the relationship between the 
outcome and several other predictors in the analyses, 
this representation of study design was forced into all 
multivariable meta-regression models.
Underlying Risk. Underlying risk refers to risk of 
the outcome (here, a NIMI with a major pathogen) 
in the population of bovine quarters not infected with 
minor pathogens, and accounts for several unmea-
sured variables in a population. Significant variation 
was found in the underlying risk among studies—48 
different values ranging from an odds of 0.01 to 36.2 
were calculated—and underlying risk was a significant 
predictor in unconditional analysis. Because underlying 
risk is inherently related to the OR, the use of meta-
regression alone for evaluation of its contribution to 
heterogeneity is not adequate (Dohoo et al., 2007). 
To further evaluate the effect of heterogeneity due to 
underlying risk, a recommended maximum likelihood 
random-slopes model was fit and compared with the 
outcomes from standard meta-regression. This model 
resulted in a coefficient estimate (β) very close to the 
value of β estimated by standard meta-regression (β = 
−0.45, SE = 0.06 in recommended model, β = −0.50, 
SE = 0.06 in meta-regression). Because this value was 
in close agreement and was not much less than zero, the 
bias in estimation of the outcome and of β by standard 
tools was assumed to be small, and the use of standard 
meta-regression was deemed sufficient (Dohoo et al., 
2007).
As underlying risk in a study increased, the amount 
of protection due to minor pathogens estimated by 
that study also increased. Underlying risk was seen to 
be much lower in observational studies (mean odds of 
major pathogen NIMI in quarters not infected with mi-
nor pathogens = 1.8) as opposed to challenge-challenge 
studies (mean odds = 4.5) or natural-challenge stud-
ies (mean odds = 10.0). Underlying risk was not sig-
nificantly associated with the outcome in observational 
studies. Underlying risk was a significant predictor in 
challenge studies, however, with a similar level of ef-
fect in both challenge-challenge and natural-challenge 
studies.
Unconditional Analyses of Other Factors. Sev-
eral study-level factors proved to be significant predic-
tors of the heterogeneity among studies in unconditional 
analyses. Because of the multiple comparisons made, 
Bonferroni correction should be applied to decrease 
type I error, and P-values were divided by 34 to evalu-
ate significance (only factors with P-values <0.0015 
would be considered statistically significant). Several 
predictors would have been significant after Bonfer-
roni correction or were close enough to significance to 
be of specific interest. Table 1 provides an overview 
of the factors investigated, their unconditional associa-
tions with the outcome, and the amount of variation 
explained by each factor.
Briefly, the odds of a study finding an increased risk 
of major pathogen NIMI caused by minor pathogen IMI 
increased through the years, and the season in which 
the study took place was significant, although the ma-
jor difference was among studies performed over all 4 
seasons and those that did not declare in which season 
they were performed (mainly short trials). These short-
er studies were more likely to find a protective effect of 
minor pathogens than were studies conducted over a 
longer period. Studies conducted on a combination of 
research and commercial farms found significantly more 
risk of minor pathogen IMI than studies conducted on 
commercial farms, and no significant differences were 
observed among studies conducted on research farms 
and those conducted on commercial operations (P = 
0.07), although a trend was found for studies on re-
search facilities to detect protection. Studies that took 
samples more often were more likely to find a protec-
tive effect of minor pathogens. Requiring that minor 
or major pathogen IMI be found in duplicate samples, 
consecutive samples, or in samples from cows diagnosed 
with clinical mastitis (a more stringent requirement for 
IMI diagnosis than just finding it in single samples) was 
associated with an increased likelihood of identifying 
minor pathogen IMI as risk factors. Studies that failed 
to report loss of study subjects to follow-up were also 
more likely to find increased risk associated with minor 
pathogen IMI than were studies that did report loss to 
follow-up (P = 0.001).
Multivariable Model. Eighteen of the 34 factors 
assessed by unconditional analyses had P ≤ 0.05 be-
fore Bonferroni correction, and so were investigated 
further in multivariable meta-regressions (Table 1). A 
multivariable model with study design, minor pathogen 
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IMI definition, and breed was built, which explained 
58.0% of the between-study heterogeneity (τ2 reduced 
from 1.67 to 0.70; Table 3). Challenge-challenge studies 
were significantly more likely to find protection than 
observational studies, as were natural-challenge studies. 
Studies where minor pathogen IMI was only diagnosed 
if the minor pathogen appeared in duplicate samples, 
consecutive samples, or in samples from quarters with 
clinical mastitis (as opposed to single samples) were 
significantly more likely to show an increased risk 
of major pathogen NIMI by minor pathogen IMI. A 
similar effect was also seen for studies in which major 
pathogen NIMI was stringently defined, but these 2 
variables were very collinear and the effect was greater 
for minor pathogens, so the minor pathogen variable 
was included in the multivariable model. To avoid type 
I errors occurring due to inclusion of multiple predictors 
in the multivariable meta-analysis, a random permuta-
tion test based on Monte Carlo simulation was used 
to provide a multiplicity adjustment of the P-values 
(Harbord and Higgins, 2008). To provide sufficient pre-
cision, the command was set to 20,000 permutations 
and results were compared with those obtained in the 
multivariable model. Challenge-challenge and natural-
challenge studies remained significantly different from 
observational studies (P = 0.001 and P = 0.04, respec-
tively), and diagnosis of minor pathogen IMI requir-
ing duplicate, consecutive, or clinical mastitis was still 
significantly different from diagnosis on single samples 
alone (P = 0.009). The P-value for the increased risk 
for studies conducted on Jerseys compared with Hol-
steins became borderline significant (P = 0.07).
Underlying risk was not included in the above model 
because it was believed to be an intervening variable, 
coming between the role of study design and the out-
come (lnOR) on the causal pathway. To build a model 
representing the role study design played, therefore, 
underlying risk could not be included. Underlying risk 
was, however, believed to account for much of the het-
erogeneity in the outcome, so adding it to a multivari-
able model was of interest. Study design also needed to 
be included in such a model, because it was believed to 
have a confounding effect on the underlying risk. An-
other multivariable model was built including underly-
ing risk, therefore, that was able to account for 81.7% 
of heterogeneity among studies (data not shown). This 
model was similar to the model presented in Table 3, 
but breed was found to be associated with underlying 
risk in simple linear regression, so was not included. The 
true effect of study design was obscured in this model, 
although the effect of minor pathogen IMI diagnosis 
was relatively unchanged. This model revealed that, 
as the risk of a major pathogen NIMI in quarters not 
infected with a minor pathogen increased, the odds of 
such a study identifying overall risk for major pathogen 
NIMI decreased (i.e., studies with higher underlying 
risk found more protective effects of minor pathogens; 
OR 0.61 compared with no effect, P < 0.001).
Factors Specific to Observational and Chal-
lenge Studies. Because of their intrinsic differences, 
certain factors relating specifically to challenge studies 
and observational studies were evaluated separately. 
Studies where cows were housed in conditions similar 
to those in the field were more likely to identify risk 
caused by minor pathogens than those that did not 
describe housing conditions, but this result was not sig-
nificant when a Bonferroni correction was applied, nor 
was it significant in further multivariable model build-
ing. This indicates that differences among observational 
studies can be mostly explained by factors that were 
common to both observational and challenge studies 
(Table 1). Several exclusive predictors were significant 
Table 3. Multivariable meta-regression model to explain heterogeneity1 among 68 studies on the effect of minor pathogen IMI on acquisition 
of new IMI with major pathogens 
Variable Odds ratio 95% CI P-value τ2
Null model 0.55 0.38, 0.81 0.003 1.67
Multivariable model    0.70
 Intercept 0.53 0.24, 1.15 0.11  
 Study type     
  Observational study Baseline    
  Challenge-challenge study 0.15 0.07, 0.35 <0.001  
  Natural-challenge study 0.19 0.07, 0.54 0.002  
 IMI definition, minor pathogen     
  Based on single sample Baseline    
  Based on duplicate, consecutive or clinical mastitis samples 4.66 1.95, 8.50 <0.001  
  Not described 1.22 0.45, 3.32 0.69  
 Breed     
  Holstein Baseline    
  Jersey 4.66 1.68, 12.94 0.004  
  Other 0.88 0.41, 1.88 0.90  
1τ2 = between-study variance or heterogeneity. 
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for challenge studies, however, and in unconditional 
analyses appeared to explain a significant portion of 
the heterogeneity among studies. Studies that included 
cows naturally infected with minor pathogens in chal-
lenge studies were more likely to identify a protective 
effect of minor pathogens than studies using uninfected 
cows (P < 0.001). Studies that did not report whether 
they tested cows before major pathogen challenge were 
also more likely to find a protective effect of minor 
pathogens (P = 0.03). Route of administration of minor 
and major pathogens was also significantly associated 
with the outcome. Studies where minor or major patho-
gens were administered via immersion of the teat in an 
infective broth (teat dip) reported less protection than 
those involving direct infusion of minor pathogens into 
the teat (intracisternal injection or cannulation into the 
teat cistern or teat duct; P < 0.001). As the interval 
between minor pathogen diagnosis and major pathogen 
challenge increased, the amount of protection afforded 
by minor pathogen IMI decreased (P < 0.001).
Predictors that were significant (P ≤ 0.05) in un-
conditional analyses (before Bonferroni correction) 
were evaluated for collinearity with study design using 
tabulation for categorical predictors and simple linear 
regression for continuous predictors. All predictors that 
were not collinear with study design retained their sig-
nificance (Table 1). These predictors were evaluated 
for collinearity with one another, and then entered into 
multivariable models in a stepwise fashion to achieve a 
maximum R2 while maintaining statistical significance 
for the predictors. A model explaining 66.3% of the het-
erogeneity between studies resulted, which contained 
study design, major pathogen dose, and whether or not 
a study adequately reported the challenge protocols 
(Table 4). Study design was not significant in uncondi-
tional analyses among challenge studies, nor was it sig-
nificant in the multivariable model. In studies utilizing 
major pathogen doses >500 cfu/mL, the amount of pro-
tection afforded by minor pathogen IMI was decreased 
(lnOR increased). Studies that did not report the dose 
of major pathogen used in experimental challenge also 
showed a decreased amount of protection compared 
with studies that used the smaller dose. Studies that 
did not adequately report challenge protocols were all 
smaller (<40 cows) and showed an overall more protec-
tive effect of minor pathogens on acquisition of NIMI 
with major pathogens (lnOR decreased). The random 
permutation multiplicity adjustment was also applied 
to this model at a setting of 20,000 permutations, and 
the P-value for the reporting of challenge protocols re-
mained significant (P = 0.02), as did the difference seen 
Table 4. Multivariable meta-regression model to explain heterogeneity1 among 37 challenge studies on the 
effect of minor pathogen IMI on acquisition of new IMI with major pathogens 
Variable Odds ratio 95% CI P-value τ2
Null model 0.32 0.17, 0.59 0.001 2.34
Multivariable model    0.80
 Intercept 0.20 0.08, 0.54 0.002  
 Study type     
  Challenge-challenge study Baseline    
  Natural-challenge study 1.31 0.41, 4.18 0.64  
 Dose of major pathogen administered     
  ≤500 cfu/mL Baseline    
  >500 cfu/mL 3.71 1.27, 10.91 0.02  
  Not described 11.94 3.25, 44.26 0.001  
 Description of challenge protocols     
  Adequately described Baseline    
  Inadequately described 0.15 0.05, 0.44 0.001  
1τ2 = between-study variance or heterogeneity. 
Figure 5. Funnel plot of the individual study odds ratio (OR) 
estimates for the effect of CNS and Corynebacterium bovis IMI on 
acquisition of new IMI with major pathogens for challenge studies. 
Small-study effects are evidenced by the presence of numerous studies 
with small OR (x-axis) and large standard errors (y-axis) on the left 
hand side of the plot. Color version available in the online PDF.
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between nonreporting of major pathogen challenge dose 
versus the lower dose (P = 0.005).
Data Subsets. Many of the same factors were signif-
icant in meta-regressions for the data subsets (CNS and 
all major pathogens, C. bovis and all major pathogens, 
CNS and Staph. aureus, C. bovis and Staph. aureus), 
although it was more difficult to build multivariable 
meta-regression models for these subsets due to the 
smaller numbers of studies. Of note was that the thresh-
old for diagnosis with either a minor pathogen or major 
pathogen was a significant predictor of the outcome in 
the data subset for CNS with all major pathogens, even 
when modeled with study design. These 2 variables ac-
counted for 44.0% of the heterogeneity between studies. 
Similar to previous results, challenge studies showed 
more protection than observational studies. Studies 
that used a liberal diagnosis for IMI or NIMI (<100 
cfu/mL) were more likely to identify a protective effect 
of minor pathogens (OR decreased to 0.30 compared 
with no effect, P = 0.08) than those using ≥100 cfu/
mL, as were studies that did not specify the threshold 
used for diagnosis with IMI (OR decreased to 0.18 com-
pared with no effect, P = 0.01).
Publication Bias or Small-Study Effects
Funnel plots were generated and used to visually as-
sess the evidence for publication bias or small-study 
effects (Figure 5). Study size (and therefore study SE) 
was confounded by study type, so observational stud-
ies and challenge studies were assessed separately. The 
graph for observational studies looked roughly sym-
metrical (data not shown), and the Egger’s test for fun-
nel plot asymmetry gave little evidence for small-study 
effects (P = 0.31). Challenge studies, however, were 
distributed more on the left side of the graph (Figure 
5), with 2 small studies showing protective effects of 
minor pathogens and large standard errors being evi-
dent in the left lower quadrant. No small studies show-
ing increased risk of minor pathogens were seen in the 
corresponding right lower quadrant. Studies of moder-
ate size were identified in the right middle of the plot, 
but substantially more moderately sized studies existed 
in the left middle. The Egger’s test indicated evidence 
for small-study effects (P = 0.04) when only challenge 
studies were assessed. An attempt to impute estimates 
for types of studies that might be missing from the 
literature review (trim-and-fill method) resulted in no 
changes to the data (Steichen, 2000).
DISCUSSION
A wide variety of literature pertaining to minor and 
major mastitis pathogen interaction exists. The stud-
ies selected for this meta-analysis, however, pertain 
specifically to minor pathogen IMI and its effects on 
the acquisition of major pathogen NIMI. During the 
literature search, several papers addressing questions of 
somatic cell count differences, duration of major patho-
gen infections in quarters previously or concomitantly 
infected with minor pathogens, morphological changes 
in the mammary gland after minor and major patho-
gen infections, and the effects of minor pathogens not 
specifically causing IMI (e.g., on teat apices) were also 
identified. Although research in these areas provides 
additional insight into the effects of minor pathogens 
in the bovine udder, these studies did not address the 
specific research question set for the analyses presented 
here. As such, these types of investigations and the 
information they contain can be used to augment work 
such as that presented here to provide further insight 
into the interactions between minor and major patho-
gens.
Meta-Analyses
It is emphasized again that, because of the large 
amount of heterogeneity among these studies, estima-
tion of an overall effect of minor pathogens has limited 
utility. The meta-analyses presented here do suggest 
overall, however, that minor pathogens have a protec-
tive effect against NIMI with major pathogens. When 
broken down further, this effect was drawn from the 
results of challenge studies, as the result for observa-
tional studies was very close to the value for no ef-
fect and was not statistically significant (Table 2). 
Challenge studies, then, seem to show overwhelmingly 
more protection by minor pathogens, for reasons to be 
discussed below. Studies that could not be included 
in the meta-analysis because they did not report OR 
reported differing effects, with Spencer et al. (1968), 
Hogan et al. (1988), Woolford et al. (2001), and Zadoks 
et al. (2001a,b) all showing either an increase or no 
difference in the major pathogen infection in quarters 
infected with minor pathogens. The paper by Michel et 
al. (2011) describes greater prevalence of CNS in herds 
with lower prevalence of Staph. aureus, which might be 
inferred as protection by CNS against Staph. aureus.
The effects of the minor pathogens when separated 
were somewhat less clear. The CNS showed a strong 
protective effect against the major pathogens, whereas 
the protective effect was less pronounced, and did not 
achieve statistical significance, for C. bovis. As many 
authors have suggested, differences undoubtedly exist 
in the effects of the minor pathogens on the differing 
major pathogens, although this becomes more difficult 
to sort out because total numbers of studies for major 
pathogens other than Staph. aureus are low and, be-
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cause of this low power, analyses are unable to show 
differences beyond what might be attributed to chance.
Several protective mechanisms of minor pathogens 
have been investigated or suggested. Nonspecific ac-
tivation of the immune system through host defense 
mechanisms such as increase in somatic cell count and 
differential cell count have been investigated and play 
a role in the interplay between pathogens in the bovine 
udder (Schukken et al., 1999; Pyörälä and Taponen, 
2009). Production of bacteriocins and other inhibitory 
substances by minor pathogens have been suggested, 
as have stimulation of anti-staphylococcal antibody 
production by the host, alteration of fatty acid concen-
tration, and general inhibition of major pathogen pas-
sage through the teat canal (Brooks and Barnum, 1984; 
Nickerson and Boddie, 1994; Schukken et al., 1999; 
Pyörälä and Taponen, 2009). These are all plausible 
explanations for the protection evidenced by the results 
presented here; however, it is beyond the scope of these 
analyses to suggest the reasons behind the protective 
effects or to lend credence to any particular theory.
Underlying Risk
Dohoo et al. (2007) have shown that, even with an 
underlying risk coefficient equal to −2, the amount of 
bias in the outcome achieved by standard meta-analysis 
is limited. Because the recommended maximum likeli-
hood random-slopes model gave coefficient estimates 
comparable to those given by standard meta-regression, 
this value was assumed to be accurate. Underlying 
risk accounted for a large amount of the heterogeneity 
among studies; its inclusion in a multivariable model 
resulted in an increase in the amount of heterogene-
ity explained by the model (e.g., adjusted-R2 increased 
from 58.0 to 81.7%). Underlying risk may be a surrogate 
for the unmeasured factors contributing to variations in 
study populations (Dohoo et al., 2007), so its account-
ing for a significant proportion of the heterogeneity is 
not surprising. Although this paper sought to evaluate 
sources of heterogeneity among the included studies, 
many factors still remain unaccounted for.
Meta-Regressions
In unconditional associations (Table 1), the amount 
of heterogeneity accounted for by each of these predic-
tors is substantial, with a total in excess of 100%, as 
many of them are representing the same information 
(they are collinear). Because of this collinearity, many 
of the predictors that were significantly associated with 
the outcome in unconditional analyses could not be 
included in the multivariable model.
Although study design was not found to account for 
much of the between-study heterogeneity (adjusted-R2 
= 7.8%) in unconditional analysis, it was significant in 
the multivariable model, where both challenge-challenge 
and natural-challenge studies found more protection 
by minor pathogens than did observational studies. It 
has been noted that challenge studies often bypass the 
natural defenses of the teat (e.g., teat orifice, keratin 
plug) because pathogens are infused directly into the 
teat canal or teat cistern. In these studies, the majority 
of natural-challenge studies (8/9) had major pathogens 
administered directly into the teat, whereas among 
challenge-challenge studies administration was more 
varied (7 into the teat, 10 by immersion, and 9 that 
did not specify a route). The only challenge studies 
that identified minor pathogens as risk factors for ma-
jor pathogen NIMI, however, were those that admin-
istered major pathogen via teat immersion. This was 
also found in unconditional analyses: studies infusing 
major pathogens into the teat (either by intracisternal 
injection or cannulation) identified minor pathogens as 
having much more of a protective effect than studies 
using teat immersion (OR decreased to 0.09 compared 
with no effect, P < 0.001) or observational studies (OR 
decreased to 0.15 compared with no effect, P < 0.001). 
This relationship also held true in the data subsets for 
CNS and all major pathogens (OR decreased to 0.05 
compared with teat dip or observational studies, P < 
0.001 for both) and for CNS and Staph. aureus (OR de-
creased to 0.05 compared with teat dip, P = 0.007; OR 
decreased to 0.03 compared with observational studies, 
P = 0.001), but was borderline significant in the data 
subset for C. bovis and all major pathogens (OR for 
infused teats decreased to 0.18, P = 0.05; observational 
studies showed no difference, P = 0.23) and completely 
nonsignificant in the data subset with C. bovis and S. 
aureus. This predictor alone represented >87% of the 
heterogeneity among studies in both the CNS and C. 
bovis major pathogen data subsets.
It has been proposed that activity at the teat end 
makes the difference in penetration and eventual NIMI 
occurrence with major pathogens. Several authors 
have suggested that minor pathogens break down teat 
defenses or interfere with the keratin plug, allowing 
major pathogens to penetrate and initiate infection 
(Hogan et al., 1988; Williamson et al., 1995; Zadoks 
et al., 2001b; Berry and Hillerton, 2002a,b). It has also 
been shown that the presence of subclinical mastitis 
aids in the growth of major pathogens in the udder 
by the release of nutrients necessary for their survival 
(Mattila et al., 1984; Mattila and Sandholm, 1986; Kitt 
and Leigh, 1997). It may be that minor pathogens are 
protective against major pathogens once inside the ud-
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der, although they also may increase susceptibility to 
major pathogens accessing the udder tissue. If minor 
pathogens are indeed operating in different ways in dif-
ferent parts of the udder, this might explain why many 
challenge studies using infusion of major pathogens 
identify protection, whereas challenge studies using teat 
immersion and observational studies (in which major 
pathogens must access the udder via the teat end) often 
identify increased risk or no effect of minor pathogen 
IMI on acquisition of new major pathogen NIMI.
The protective effect of minor pathogen IMI on ac-
quisition of a major pathogen NIMI was more likely to 
be seen in studies that utilized a more lenient definition 
of when an IMI exists or when a NIMI occurs. This 
was evident not only in IMI definitions in the larger 
data set but also in IMI threshold restrictions in the 
data subset with CNS and major pathogens. Stringent 
requirements for defining when an IMI exists or when a 
NIMI occurs mean that the specificity of diagnosis will 
be high, but at the cost of reduced sensitivity. Hence, 
although false positive diagnoses are minimized, false 
negative diagnoses will increase. Low sensitivity of bac-
teriological culture for the majority of pathogens has 
already been reported (Dohoo et al., 2011), and it is 
therefore possible that many of these studies underes-
timated the presence of minor pathogens and missed 
the occurrence of major pathogen NIMI. This misclas-
sification bias undoubtedly affected the associations 
presented in these studies. Because the same sampling 
and bacteriological methods were applied to samples 
from cows with and without minor pathogen infection, 
it was assumed that the misclassification would be non-
differential and, therefore, that the associations would 
be biased toward the null, meaning they may, in fact, 
be underestimated.
Challenge studies utilizing higher doses of major 
pathogens for challenge and those that did not report 
the dosages used showed minor pathogen IMI to afford 
less protection against major pathogen NIMI. It is in-
tuitive that a larger inoculum of major pathogen would 
more easily overcome any protective effect offered by 
minor pathogens, although this logic perhaps cannot 
be extended to studies that did not report the major 
pathogen dosage. Interestingly, studies without ad-
equate descriptions of challenge protocols found more 
evidence for protection by minor pathogens than those 
with full descriptions of the protocols used. Many of 
these studies did not report significant details such as 
the route of challenge administration, method of alloca-
tion of quarters to be challenged, or the time between 
challenge and sampling for diagnosis of NIMI. Although 
inadequate reporting of details such as these does not 
necessarily mean that studies were not conducted ap-
propriately, it does call into question the repeatability 
of the studies and the overall methods by which conclu-
sions were reached.
The majority of studies either did not report the 
season in which they were conducted (27/68) or were 
conducted over all 4 seasons (39/68). Studies not re-
porting the season are likely to have been conducted 
over a short period (days or weeks instead of an entire 
year) and were more likely to find a protective ef-
fect of minor pathogens. Studies not reporting season 
were also associated with more frequent sampling of 
quarters. Although minor pathogens have been shown 
to cause chronic infections in the udder (Honkanen-
Buzalski et al., 1984; Pyörälä and Taponen, 2009), it 
may be that they exhibit more of a protective effect 
over a short period than over long periods. Another 
possible explanation is that studies conducted over long 
periods may culture minor pathogens at the beginning 
of the study period (before dry-off, for instance) instead 
of identifying these pathogens very close to the time of 
major pathogen NIMI.
Sampling frequency was closely related to study de-
sign but, like publication year, seemed to account for a 
greater proportion of the heterogeneity among studies 
(29.3 vs. 7.8%). It is difficult to attribute an observed 
effect of minor pathogen IMI on major pathogen NIMI 
to the presence of minor pathogen IMI cultured 10 to 
20 wk before the occurrence of a NIMI, although this 
is what some manuscripts offered. Studies conducted 
over the dry period also identified minor pathogens 
before drying off and related their presence to the oc-
currence of major pathogen NIMI after calving, usu-
ally 6 or more weeks later. Minor pathogen infections 
may become chronic, but this cannot be assumed of 
all minor pathogen IMI during all stages of lactation, 
and conclusions from studies sampling over very long 
periods should be drawn with care.
Publication Bias or Small-Study Effects
The lack of studies showing high levels of risk 
caused by minor pathogen IMI may be an indication 
of publication bias (small studies showing increased 
risk of minor pathogens have not been published) or of 
small-study effects (smaller studies showed very protec-
tive effects of minor pathogens). In Figure 5, only 2 
small studies showed very protective effects of minor 
pathogens, and 1 small observational study showed 
very protective effects (data not shown). Studies with 
moderate sample size and estimates of increased risk 
are included (right central area of the plot), although 
more moderately sized studies show protection (left 
central area). Approximately the same number of stud-
ies showed increased risk (right) in the upper portion 
of the plot compared with studies showing protection 
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(left). If bias is present, however, and small or moder-
ate studies showing increased risk of major pathogen 
NIMI caused by minor pathogens do exist, inclusion of 
these studies would serve to move the estimate of minor 
pathogen effect closer to the null. Another explanation 
is that the moderately sized studies showing protec-
tive effects are driving the estimate of effect toward 
protection. The studies represented in this middle left 
portion of the funnel plot ranged between 4 and 40 
cows. Although this relationship was not evident in the 
univariable meta-regression with number of cows, this 
may be in part because the representation of number 
of cows was difficult and most closely approximated a 
quadratic relationship with the outcome. It can be seen 
in Figure 5, however, that the majority of small and 
moderate-sized studies showed a protective effect of mi-
nor pathogens. When studies were grouped according to 
number of cows (≤40 and >40), those involving more 
cows were seen to show more risk for minor pathogens 
(OR increased to 6.0 compared with no effect, P < 
0.001) and 35.3% of the heterogeneity among studies 
was explained. This parameter could not be included in 
multivariable models, however, because it was collinear 
with study design.
Although it may not be possible to conduct experi-
mental studies on large numbers of animals, smaller 
studies such as those reported here may suffer from a 
lack of rigorous scientific method. In the data presented 
here, all challenge studies judged to have inadequate 
protocols were studies with fewer than 40 cows. The 1 
study that was judged to have inadequate time between 
pathogen challenge and subsequent diagnosis and the 2 
studies that failed to describe this amount of time were 
also smaller studies. Moreover, smaller studies may not 
fully utilize the statistical tools available to account for 
occurrences such as interdependence, cow-level effects, 
or confounders. In thedata presented here, the 8 studies 
reporting estimates adjusted for risk factors other than 
minor pathogen infection were all >40 cows, as were all 
6 studies in which multilevel modeling was used to ac-
count for interdependence between quarters, cows and 
herds.
Egger’s test for small-study effects was significant 
for challenge studies, but not for observational studies. 
This is not surprising, because small-study effects were 
suspected on visual interpretation of the graph of chal-
lenge studies, and it is known that all tests proposed 
to evaluate small-study effects may give false positive 
results in the presence of extreme study heterogene-
ity (Harbord et al., 2009). The authors of the present 
study emphasize again that this excessive heterogeneity 
calls into question the accuracy of the estimate of effect 
given by the meta-analysis.
Other Considerations
To maximize power and detect significant differ-
ences in the meta-analyses and meta-regressions, the 2 
groups of minor pathogens and several major pathogen 
groups were combined. Although this approach makes 
it possible to delineate differences that may not be seen 
with fewer data, it certainly has drawbacks, as it is not 
expected that these pathogens all behave in the same 
manner in nature. Certainly, speciation of the group of 
pathogens referred to as CNS would be beneficial, be-
cause different species exhibit a range of chronicity and 
inflammatory effects in the mammary gland (Supré et 
al., 2011). Some attempts to further examine the effects 
of individual minor pathogens on major pathogens were 
made but resulted in nonsignificant outcomes, most 
likely due to low power.
CONCLUSIONS
A wide body of evidence exists on the subject of mi-
nor pathogen IMI and its effect on the acquisition of 
major pathogen NIMI. Significant heterogeneity among 
studies exists, some of which could be accounted for 
using meta-regression. The analyses presented here re-
veal that, overall, challenge studies showed strong and 
significant protective effects, specifically when major 
pathogens were introduced into the mammary gland by 
methods that bypassed the teat end. Observational stud-
ies were not associated with either a protective effect or 
increased risk of major pathogen NIMI. Underlying risk 
can account for several unmeasured factors in studies 
and was significant in all challenge studies, revealing 
an inverse relationship with the outcome. Larger doses 
of challenge organisms reduced the protective effect 
of minor pathogens, and studies with more stringent 
diagnostic criteria for pathogen IMI also identified less 
protection. As the interval between infection with a mi-
nor pathogen and challenge with a major pathogen in-
creased, less protection was identified. Studies in which 
samples were taken less frequently also demonstrated 
less protection, and smaller studies showed a greater 
protective effect than larger studies. The data suggest 
that, for several reasons, minor pathogens might seem 
more protective under artificial conditions than in real-
world circumstances.
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APPENDIX
Table A1. Overview and descriptive information of 38 manuscripts comprising 68 studies used in meta-analyses examining the effect of minor 
pathogen IMI on new IMI with major pathogens 
Reference/study number
Study  
design1
Minor  
pathogens2 Major pathogens3
No. of  
cows Parity4 Stage5
Aarestrup and Jensen (1997) O CNS SA, SU, SD 180 H Lact
Berry and Hillerton (2002a) I6 O CNS SA, SU, coli 290 ND Dry
Berry and Hillerton (2002a) II O CB SA, SU, coli 290 ND Dry
Berry and Hillerton (2002b) I O CNS SA, SU, coli 401 ND Dry
Berry and Hillerton (2002b) II O CB SA, SU, coli 401 ND Dry
Black et al. (1972) I O CB SA 32 ND Lact
Black et al. (1972) II O CB SAg, SU, SD, oth 32 ND Lact
Black et al. (1972) III O CB coli, oth 32 ND Lact
Black et al. (1972) IV O CB coli, oth 38 ND Lact
Black et al. (1972) V O CB SA 38 ND Lact
Black et al. (1972) VI O CB SAg, SU, SD, oth 38 ND Lact
Bramley (1975) O CB SA, SAg, SU, SD, coli ND7 ND Both
Bramley (1976) I NC CNS coli 6 H+L Lact
Bramley (1976) II NC CNS coli 4 H+L Dry
Bramley (1978) CC CNS SAg, coli 17 ND Lact
Brooks et al. (1983) O CB SA, SAg, SU, SD, coli, oth ND H+L Both
Brooks and Barnum (1984) I CC CB SA 32 ND Lact
Brooks and Barnum (1984) II CC CB SA 32 ND Lact
Brooks and Barnum (1984) III CC CB SAg 32 ND Lact
Brooks and Barnum (1984) IV CC CB SAg 32 ND Lact
Davidson et al. (1992) O CNS SA 84 L Lact
Doane et al. (1987) I NC CB SU 18 ND Lact
Doane et al. (1987) II NC CB SU 4 ND Lact
Green et al. (2002) I O CB SA, SAg, SU, SD, coli, oth 480 ND Both
Green et al. (2002) II O CB SA, SAg, SU, SD, coli, oth 480 ND Both
Green et al. (2005) I O CNS SA 480 ND Dry
Green et al. (2005) II O CB SA 480 ND Dry
Green et al. (2005) III O CB SU 480 ND Dry
Honkanen-Buzalski et al. (1984) I O CB SA, SAg, SU, SD, coli, oth 1,450 ND Both
Honkanen-Buzalski et al. (1984) II O CB SA, SAg, SU, SD, coli, oth 1,450 ND Both
Lam et al. (1997) I O CNS SA, SU, SD, coli 392 ND Both
Lam et al. (1997) II O CB SA, SU, SD, coli 392 ND Both
Linde et al. (1975a) CC CNS SA 9 ND Lact
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Table A1 (Continued). Overview and descriptive information of 38 manuscripts comprising 68 studies used in meta-analyses examining the 
effect of minor pathogen IMI on new IMI with major pathogens
Reference/study number
Study  
design1
Minor  
pathogens2 Major pathogens3
No. of  
cows Parity4 Stage5
Linde et al. (1975b) I CC CNS SA, SAg, SD 14 ND Lact
Linde et al. (1975b) II CC CNS SAg, SD 5 ND Lact
Linde et al. (1976) I CC CNS SA 6 ND Lact
Linde et al. (1976) II CC CNS SAg, SU, SD 7 ND Lact
Linde et al. (1980) I CC CNS SA 8 ND Lact
Linde et al. (1980) II CC CNS SAg, SU, SD 7 ND Lact
Linde et al. (1980) III CC CNS Coli, oth 9 ND Lact
Linde et al. (1980) IV CC CB SA, SD 2 ND Lact
Linde (1982) I CC CNS SA 8 ND Lact
Linde (1982) II CC CNS SAg, SU, SD 7 ND Lact
Linde (1982) III CC CNS Coli, oth 9 ND Lact
Matthews et al. (1990) NC CNS SA 10 ND Lact
Matthews et al. (1991) O CNS SA, SU, SD, coli, oth 113 H+L Both
Myllys (1995) O CNS SA, SU, SD, oth 50 H Dry
Newbould and Neave (1965) NC CB SA 10 H+L Lact
Nickerson and Boddie (1994) NC CNS SA, SAg 600 ND Lact
Pankey et al. (1985) I CC CB SA 57 ND Lact
Pankey et al. (1985) II CC CNS SA 57 ND Lact
Pankey et al. (1985) III CC CB SA ND ND Lact
Pankey et al. (1985) IV CC CNS SA ND ND Lact
Pankey et al. (1985) V CC CB SA ND ND Lact
Pankey et al. (1985) VI CC CNS SA ND ND Lact
Pankey et al. (1985) VII CC CB SAg ND ND Lact
Pankey et al. (1985) VIII CC CNS SAg ND ND Lact
Pankey et al. (1985) IX CC CB SAg ND ND Lact
Pankey et al. (1985) X CC CNS SAg ND ND Lact
Pankey et al. (1985) XI O CB SU ND ND Dry
Parker et al. (2007) O CNS SA, SU, SD, coli, oth 255 H Dry
Postle et al. (1978) NC CB SA 41 H+L Lact
Poutrel and Lerondelle (1980) CC CNS SA 44 H Lact
Rainard and Poutrel (1988) I O CNS SA, SAg, SU, SD 122 H+L Lact
Rainard and Poutrel (1988) II O CB SA, SAg, SU, SD 122 H+L Lact
Reyher et al. (2012) I O CNS SA, SU, SD, coli 6,825 H+L Lact
Reyher et al. (2012) II O CB SA, SU, SD, coli 6,825 H+L Lact
Schukken et al. (1999) NC CB SA 145 H+L Lact
1Study design: O = observational, CC = challenge studies where quarters were experimentally challenged both with a minor pathogen and sub-
sequently with a major pathogen, NC = challenge studies where quarters were naturally infected with a minor pathogen and challenged with a 
major pathogen.
2Minor pathogens represented: CNS, Corynebacterium bovis (CB).
3Major pathogens represented: Staphylococcus aureus (SA); Streptococcus agalactiae (SAg); Streptococcus uberis (SU); Streptococcus dysgalactiae 
(SD); coliforms (coli); other streptococci, Pseudomonas spp., yeast (oth).
4Parity: H = heifers only, L = lactating cows only, H+L = heifers and lactating cows, ND = not described.
5Stage of lactation: lact = lactation only, dry = dry period only, both = both lactation and dry period.
6Study number from a single reference.
7Not described.
